• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体中某些磺胺类药物乙酰化表型及药代动力学的测定

Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.

作者信息

Vree T B, O'Reilly W J, Hekster Y A, Damsma J E, van der Kleijn E

出版信息

Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.

DOI:10.2165/00003088-198005030-00006
PMID:7389236
Abstract

The pharmacokinetics of sulphamethizole, sulphamethoxazole, sulphadiazine, sulphapyridine and sulphadimidine have been studied in man. Renal clearance values of the metabolite N4-acetylsulphonamide are 6 to 20 times higher than those of the corresponding parent compound. The renal clearance of sulphonamides is dependent on the urine flow. N4-Acetylsulphonamide concentration-time profiles for plasma and urine have been constructed for the sulphonamides. The percentage N4-acetylsulphonamide-time profiles for plasma are excellent tools for establishing the acetylator phenotype, while those constructed from urine samples are less useful. Evidence is obtained that sulphadimidine is metabolically processes by 2 different isoenzymes, while sulphadiazine, sulphapyridine and sulphamethoxazole are processes by 1 acetylating isoenzyme. Sulphamethizole is acetylated to very little extent.

摘要

已对磺胺甲噻二唑、磺胺甲恶唑、磺胺嘧啶、磺胺吡啶和磺胺二甲嘧啶在人体中的药代动力学进行了研究。代谢产物N4-乙酰磺胺的肾清除率值比相应母体化合物的肾清除率值高6至20倍。磺胺类药物的肾清除率取决于尿流量。已构建了磺胺类药物血浆和尿液中N4-乙酰磺胺的浓度-时间曲线。血浆中N4-乙酰磺胺百分比-时间曲线是确定乙酰化表型的极佳工具,而从尿液样本构建的曲线则用处较小。有证据表明,磺胺二甲嘧啶由2种不同的同工酶进行代谢,而磺胺嘧啶、磺胺吡啶和磺胺甲恶唑由1种乙酰化同工酶进行代谢。磺胺甲噻二唑的乙酰化程度非常低。

相似文献

1
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.人体中某些磺胺类药物乙酰化表型及药代动力学的测定
Clin Pharmacokinet. 1980 May-Jun;5(3):274-94. doi: 10.2165/00003088-198005030-00006.
2
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.短效磺胺类药物及N4-乙酰磺胺衍生物在人体中的药代动力学及肾脏排泄机制。磺胺类药物主动肾小管分泌的结构要求。
Eur J Clin Pharmacol. 1981;20(4):283-92. doi: 10.1007/BF00618779.
3
Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.磺胺甲恶唑在人体中的药代动力学:尿液pH值和尿流对磺胺甲恶唑及其代谢产物N4-乙酰磺胺甲恶唑代谢和肾排泄的影响。
Clin Pharmacokinet. 1978 Jul-Aug;3(4):319-29. doi: 10.2165/00003088-197803040-00005.
4
Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.N1-乙酰基和N4-乙酰基磺胺甲恶唑在人体中的药代动力学
Clin Pharmacokinet. 1979 Jul-Aug;4(4):310-9. doi: 10.2165/00003088-197904040-00004.
5
Sulphamethoxazole acetylation in fast and slow acetylators.快速和慢速乙酰化者体内的磺胺甲恶唑乙酰化作用
Int J Clin Pharmacol Ther Toxicol. 1990 Apr;28(4):164-6.
6
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.磺胺类药物N-取代基中甲氧基对人体消除途径的影响。磺胺异嘧啶、磺胺甲嘧啶和磺胺二甲氧嘧啶的乙酰化-去乙酰化平衡及肾脏排泄机制。
Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042.
7
The metabolism of four sulphonamides in cows.四种磺胺类药物在奶牛体内的代谢
Biochem J. 1973 Dec;136(4):1039-45. doi: 10.1042/bj1361039.
8
The effect of the molecular structure of closely related N1-substituents of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and renal clearance related to the structure of sulfadiazine, sulfamerazine and sulfadimidine.磺酰胺类密切相关的N1-取代基的分子结构对人体消除途径的影响。与磺胺嘧啶、磺胺甲嘧啶和磺胺二甲嘧啶结构相关的乙酰化-去乙酰化平衡及肾清除率。
Pharm Weekbl Sci. 1983 Apr 29;5(2):49-56. doi: 10.1007/BF01960075.
9
Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.口服磺胺甲恶唑后磺胺甲恶唑羟胺的形成与消除。
Br J Clin Pharmacol. 1994 Aug;38(2):147-50. doi: 10.1111/j.1365-2125.1994.tb04339.x.
10
Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators.
Biopharm Drug Dispos. 1983 Jul-Sep;4(3):271-91. doi: 10.1002/bdd.2510040308.

引用本文的文献

1
Identification of Antibiotics in Surface-Groundwater. A Tool towards the Ecopharmacovigilance Approach: A Portuguese Case-Study.地表水中抗生素的识别:生态药物警戒方法的一种工具——葡萄牙案例研究
Antibiotics (Basel). 2021 Jul 21;10(8):888. doi: 10.3390/antibiotics10080888.
2
Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.在上行性尿路感染小鼠模型中,磺胺甲噻二唑和氨比西林对不同敏感性大肠杆菌菌株的作用。
Antimicrob Agents Chemother. 2003 Mar;47(3):1002-9. doi: 10.1128/AAC.47.3.1002-1009.2003.
3
Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

本文引用的文献

1
Acetylation of procaine amide in man studied with a new gas chromatographic method.用一种新的气相色谱法研究人体中普鲁卡因酰胺的乙酰化。
Br J Clin Pharmacol. 1974 Dec;1(6):467-75. doi: 10.1111/j.1365-2125.1974.tb01696.x.
2
Acetylator phenotype and the clinical pharmacology of slow-release procainamide.乙酰化表型与普鲁卡因胺控释剂的临床药理学。
Br J Clin Pharmacol. 1976 Dec;3(6):1023-6. doi: 10.1111/j.1365-2125.1976.tb00352.x.
3
Phenelzine in urine: assay and relation to acetylator status.尿中苯乙肼的检测及其与乙酰化状态的关系。
口服磺胺甲恶唑后磺胺甲恶唑羟胺的形成与消除。
Br J Clin Pharmacol. 1994 Aug;38(2):147-50. doi: 10.1111/j.1365-2125.1994.tb04339.x.
4
Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.多态性乙酰化:风湿性疾病活动及同时给药的无影响
Rheumatol Int. 1995;14(6):257-60. doi: 10.1007/BF00262093.
5
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.短效磺胺类药物及N4-乙酰磺胺衍生物在人体中的药代动力学及肾脏排泄机制。磺胺类药物主动肾小管分泌的结构要求。
Eur J Clin Pharmacol. 1981;20(4):283-92. doi: 10.1007/BF00618779.
6
A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.一种区分三种乙酰化表型的简单药代动力学方法:初步报告。
Br J Clin Pharmacol. 1982 Mar;13(3):375-8. doi: 10.1111/j.1365-2125.1982.tb01388.x.
7
The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups.糖尿病中的快速乙酰化酶表型:异常患病率及其与ABO血型的关联。
Diabetologia. 1984 Aug;27(2):235-7. doi: 10.1007/BF00273812.
8
Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.磺胺类药物N-取代基中甲氧基对人体消除途径的影响。磺胺异嘧啶、磺胺甲嘧啶和磺胺二甲氧嘧啶的乙酰化-去乙酰化平衡及肾脏排泄机制。
Pharm Weekbl Sci. 1984 Aug 24;6(4):150-6. doi: 10.1007/BF01954042.
9
Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
Eur J Clin Pharmacol. 1981;21(3):243-50. doi: 10.1007/BF00627927.
10
Ageing and acetylator phenotype as determined by administration of sulphadimidine.通过给予磺胺二甲嘧啶确定的衰老与乙酰化酶表型。
Eur J Clin Pharmacol. 1985;28(4):485-6. doi: 10.1007/BF00544374.
Br J Clin Pharmacol. 1976 Aug;3(4):633-7. doi: 10.1111/j.1365-2125.1976.tb04887.x.
4
GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN, NEGRO, AND JAPANESE POPULATIONS.高加索人、黑人和日本人中异烟肼代谢的遗传学
Science. 1964 Jul 24;145(3630):391.
5
HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性
J Lab Clin Med. 1964 Mar;63:394-403.
6
Control of urine pH and its effect on sulfaethidole excretion in humans.人体尿液pH值的控制及其对磺胺乙噻唑排泄的影响。
J Pharm Sci. 1962 Nov;51:1084-9. doi: 10.1002/jps.2600511117.
7
Genetical and geographic studies on isoniazid inactivation.关于异烟肼失活的遗传学和地理学研究。
Science. 1961 Nov 10;134(3489):1530-1. doi: 10.1126/science.134.3489.1530.
8
Diurnal variations in the elimination rate of a sulfonamide in man.人体内一种磺胺类药物消除率的昼夜变化。
Helv Med Acta. 1967 Jan;33(4):291-306.
9
The discrimination of phenotypes for rate of disappearance of isonicotinoyl hydrazide from serum.血清中异烟酰肼消失速率的表型鉴别
J Clin Invest. 1969 Jul;48(7):1173-6. doi: 10.1172/JCI106081.
10
The mechanism of isoniazid acetylation by human N-acetyltransferase.
Biochim Biophys Acta. 1968 Jan 8;151(1):276-8. doi: 10.1016/0005-2744(68)90184-8.